Open AccessMicro RNA Expression in Circulating Microvesicles Predicts Cardiovascular Events in Patients With Coronary Artery Disease
Author(s) -
Jansen Felix,
Yang Xiaoyan,
Proebsting Sebastian,
Hoelscher Marion,
Przybilla David,
Baumann Katharina,
Schmitz Theresa,
Dolf Andreas,
Endl Elmar,
Franklin Bernardo S.,
Sinning JanMalte,
VasaNicotera Mariuca,
Nickenig Georg,
Werner Nikos
Publication year - 2014
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.114.001249
Subject(s) - medicine , hazard ratio , coronary artery disease , cardiology , adverse effect , microrna , proportional hazards model , univariate analysis , confidence interval , multivariate analysis , biochemistry , chemistry , gene
Background Circulating micro RNA s (mi RNA s) are differentially regulated and selectively packaged in microvesicles (MVs). We evaluated whether circulating vascular and endothelial mi RNA s in patients with stable coronary artery disease have prognostic value for the occurrence of cardiovascular ( CV ) events. Methods and Results Ten mi RNA s involved in the regulation of vascular performance—miR‐126, miR‐222, miR‐let7d, miR‐21, miR‐20a, miR‐27a, miR‐92a, miR‐17, miR‐130, and miR‐199a—were quantified in plasma and circulating MV s by reverse transcription polymerase chain reaction in 181 patients with stable coronary artery disease. The median duration of follow‐up for major adverse CV event–free survival was 6.1 years (range: 6.0–6.4 years). Events occurred in 55 patients (31.3%). There was no significant association between CV events and plasma level of the selected mi RNA s. In contrast, increased expression of miR‐126 and miR‐199a in circulating MV s was significantly associated with a lower major adverse CV event rate. In univariate analysis, above‐median levels of miR‐126 in circulating MV s were predictors of major adverse CV event–free survival (hazard ratio: 0.485 [95% CIAUTHOR : Is 95% CI correct?: 0.278 to 0.846]; P =0.007) and percutaneous coronary interventions (hazard ratio: 0.458 [95% CI : 0.222 to 0.945]; P =0.03). Likewise, an increased level of miR‐199a in circulating MV s was associated with a reduced risk of major adverse CV events (hazard ratio: 0.518 [95% CI : 0.299 to 0.898]; P =0.01) and revascularization (hazard ratio: 0.439 [95% CI : 0.232 to 0.832]; P =0.01) in univariate analysis. mi RNA expression analysis in plasma compartments revealed that miR‐126 and miR‐199a are present mainly in circulating MV s. MV ‐sorting experiments showed that endothelial cells and platelets were found to be the major cell sources of MV s containing miR‐126 and miR‐199a, respectively. Conclusion MV s containing miR‐126 and miR‐199a but not freely circulating mi RNA expression predict the occurrence of CV events in patients with stable coronary artery disease.